Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
60°
Sunny
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about NBIX
Recent news which mentions NBIX
< Previous
1
2
3
4
5
6
Next >
What Analysts Are Saying About Neurocrine Biosciences Stock
December 20, 2024
Tickers
NBIX
Tags
BZI/AAR
Benzinga
NBIX
From
Benzinga
Neurocrine's Drug Gains FDA Nod As First Targeted Treatment For Certain Type Of Inherited Disorder, Analyst Highlights Blockbuster Potential
December 16, 2024
Tickers
CRNX
NBIX
NEWS
Tags
General
Top Stories
Briefs
From
Benzinga
Screening For Black Friday Bargains In The Stock Market
December 03, 2024
Tickers
EXPE
NBIX
NVDA
SUPN
Tags
SUPN
NBIX
EXPE
From
Benzinga
AbbVie's Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio
November 12, 2024
Tickers
ABBV
BMY
NBIX
NEWS
Tags
Expert Ideas
Biotech
Benzinga
From
Benzinga
In-Depth Examination Of 20 Analyst Recommendations For Neurocrine Biosciences
October 29, 2024
Tickers
NBIX
Tags
BZI/AAR
NBIX
Analyst Ratings
From
Benzinga
Critical Insights From Neurocrine Biosciences Analyst Ratings: What You Need To Know
October 04, 2024
Tickers
NBIX
Tags
Analyst Ratings
Market News
NBIX
From
Benzinga
"Rule Breaker Investing" Market Cap Game Show: Throwdowns & Long-Term Wins
September 30, 2024
Tickers
AMD
HEI
KFRC
LOW
Tags
LOW
NBIX
KFRC
From
Motley Fool
Neurocrine Shifts Focus To New Schizophrenia Treatment After Luvadaxistat Trial Misses Endpoint
September 13, 2024
Tickers
NBIX
NEWS
Tags
Briefs
General
Analyst Color
From
Benzinga
Decoding 19 Analyst Evaluations For Neurocrine Biosciences
September 09, 2024
Tickers
NBIX
Tags
Benzinga
Market News
Analyst Ratings
From
Benzinga
Intel, Moderna And Dollar General Were Among Top 10 Large Cap Losers In August: Are The Others In Your Portfolio?
September 08, 2024
Tickers
CRL
DG
GFI
INTC
Tags
TME
SNAP
Benzinga
From
Benzinga
Dollar General, Temu Parent PDD And Super Micro Computer Are Among Top 10 Large Cap Losers Last Week (Aug 25-Aug 31): Are The Others In Your Portfolio?
September 02, 2024
Tickers
COIN
DG
DLTR
MSTR
Tags
DG
Trading Ideas
SMCI
From
Benzinga
Why Neurocrine Biosciences Stock Was Tumbling This Week
August 30, 2024
Tickers
NBIX
Tags
NBIX
Market News
Recent Press Releases
From
Motley Fool
Neurocrine Biosciences' Lower Dose Data Puts Its Schizophrenia Candidate In The Game, Analyst Upgrades Stock
August 29, 2024
Tickers
NBIX
NEWS
Tags
Briefs
Movers
Upgrades
From
Benzinga
NVIDIA To Rally Over 31%? Here Are 10 Top Analyst Forecasts For Thursday
August 29, 2024
Tickers
CRM
CRWD
EQNR
HPQ
Tags
Analyst Ratings
HPQ
CRM
From
Benzinga
Nasdaq Down Over 1%; Foot Locker Shares Tumble After Q2 Results
August 28, 2024
Tickers
ATPC
AVAV
BOF
FL
Tags
News
FL
NBIX
From
Benzinga
As Regulators Gear Up To Decide On Bristol Myers' Schizophrenia Treatment, Neurocrine Biosciences' Data Disappoints Investors
August 28, 2024
Tickers
ABBV
BMY
NBIX
NEWS
Tags
Market News
NBIX
Health Care
From
Benzinga
US Stocks Mixed; JM Smucker Slashes Annual Guidance
August 28, 2024
Tickers
ATPC
BOF
BSLK
NBIX
Tags
Equities
Trading Ideas
BOF
From
Benzinga
Regulators Expected To Approve Innovative Schizophrenia Treatment From Bristol Myers, Karuna
August 27, 2024
Tickers
ABBV
BMY
LLY
NBIX
Tags
Top Stories
Benzinga
LLY
From
Benzinga
Evaluating Neurocrine Biosciences: Insights From 15 Financial Analysts
August 19, 2024
Tickers
NBIX
Tags
Benzinga
Market News
Analyst Ratings
From
Benzinga
9 Health Care Stocks Whale Activity In Today's Session
August 13, 2024
Tickers
BPMC
EW
EXAS
IBRX
Tags
PFE
VRNA
EXAS
From
Benzinga
A Closer Look at 7 Analyst Recommendations For Neurocrine Biosciences
August 01, 2024
Tickers
NBIX
Tags
Analyst Ratings
Market News
NBIX
From
Benzinga
Cracking The Code: Understanding Analyst Reviews For Neurocrine Biosciences
July 10, 2024
Tickers
NBIX
Tags
BZI/AAR
Analyst Ratings
Market News
From
Benzinga
7 Breakthrough Biotech Stocks for a Shot of Portfolio Adrenaline
June 17, 2024
Tickers
AMGN
BLUE
BMY
GILD
Tags
Market News
BLUE
NBIX
From
InvestorPlace
Key Takeaways From Neurocrine Biosciences Analyst Ratings
May 28, 2024
Tickers
NBIX
Tags
BZI/AAR
Benzinga
Analyst Ratings
From
Benzinga
Cracking The Code: Understanding Analyst Reviews For Neurocrine Biosciences
May 01, 2024
Tickers
NBIX
Tags
BZI/AAR
Benzinga
Market News
From
Benzinga
NBIX Stock Earnings: Neurocrine Biosciences Beats EPS, Beats Revenue for Q1 2024
May 01, 2024
Tickers
NBIX
Tags
Earnings Reports
NBIX
Market News
From
InvestorPlace
3 Red-Hot Biotech Rockets Blasting Off in 2024
April 24, 2024
Tickers
GERN
NBIX
VKTX
Tags
GERN
Market News
NBIX
From
InvestorPlace
Neurocrine Biosciences Says Treatment Can Alleviate Several Symptoms Associated With Depressive Disorder
April 23, 2024
Tickers
NBIX
NEWS
TAK
Tags
Market News
NBIX
News
From
Benzinga
Where Neurocrine Biosciences Stands With Analysts
April 10, 2024
Tickers
NBIX
Tags
BZI/AAR
Market News
Analyst Ratings
From
Benzinga
Analyst Bullish On Gene Therapy-Focused Voyager Therapeutics Sees Best In Class Potential For Its Neurogenetic Medicine Platform
March 19, 2024
Tickers
AZN
NBIX
NEWS
NVS
Tags
Analyst Ratings
Trading Ideas
Equities
From
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
